We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Association between Rheumatic Disease Comorbidity Index and factors of poor prognosis in a cohort of 280 patients with rheumatoid arthritis.
- Authors
Ben Tekaya, Aicha; Hannech, Emna; Saidane, Olfa; Rouached, Leila; Bouden, Selma; Tekaya, Rawdha; Mahmoud, Ines; Abdelmoula, Leila
- Abstract
Background: Rheumatoid arthritis (RA) is commonly associated with higher rates of comorbidities. Recent recommendations highlight screening comorbidities during the disease course because of their impact on patients' ability to function, on disease outcome, but also on treatment choices. Hence the interest of our study that aimed to quantify the impact of comorbidities among RA patients using a validated tool the Rheumatic Disease Comorbidity Index (RDCI) and to explore the association between comorbidities and disease characteristics. Methods: We conducted a cross-sectional study over 12 months period, including patients followed for an established RA according to the ACR/EULAR 2010 criteria and hospitalized in our rheumatology department. Patients' characteristics and disease features were collected for each patient. Comorbidities were quantified using the RDCI. We looked for the association between RDCI and patients characteristics and RA parameters. Univariable and multivariable analysis were made. Results: They were 280 patients: 233 female (83.2%) and 47 male (16.8%) with a mean age of 58.07 (SD 11.12) years. The mean follow-up period was 14.74 (SD 1.63) years. Comorbidities were noted in 133 patients (47.5%). The mean comorbidity score measured by the RDCI was 1.05 (SD 1.23). RDCI was positively correlated with age (p < 0.001, r = 0.359). RA patients whose age of disease onset exceeds 40 years have significantly higher RDCI (1.8 (SD 1.3) [CI 95%: 1.36–1.88] vs. 1.5 (SD 1.2), p = 0.007). Moreover, RDCI was significantly associated with the presence pulmonary involvement (p < 0.001) and ocular involvement (p = 0.002). RDCI was also associated with erosive RA (p = 0.006), the presence of atlanto-axial dislocation (p = 0.014), and coxitis (p = 0.029). Regarding therapy regimen, RDCI was statistically increased in patients receiving bDMARDs compared to patients under csDMARDs (2.8 (SD 1.6) vs. 1.0 (SD 1.0), p = 0.021). Conclusion: In this study, comorbidity index was associated with signs of poor prognosis such as erosions, coxitis, and atlanto-axial dislocation. This confirmed the hypothesis that comorbidity can be a threat to the improvement in the long-term prognosis in RA patients. Highlights: Patients with rheumatoid arthritis have higher rate of comorbidity which may impair their quality of life and affects disease outcomes. Rheumatic Disease Comorbidity Index (RDCI) is an excellent tool to predict extra-articular manifestations and signs of poor prognosis such as erosions, coxitis, and atlanto-axial dislocation. An early screening and an adequate management of comorbidities may result in better disease outcomes.
- Publication
BMC Rheumatology, 2022, Vol 6, Issue 1, p1
- ISSN
2520-1026
- Publication type
Article
- DOI
10.1186/s41927-022-00308-5